EVIDENCE LIBRARY
Intranasal Dental-Sedation Review Compared Onset Across Heterogeneous Studies Rather Than One Trial
A twenty-study review described intranasal sedatives used in children. Its reported onset and success figures should not be mistaken for a single randomized comparison.
A twenty-study review described intranasal sedatives used in children. Its reported onset and success figures should not be mistaken for a single randomized comparison.
What the review assembled
The authors searched Medline for English-language pediatric dental studies involving intranasal agents. Midazolam was most frequently represented, with ketamine, sufentanil, and other drugs also discussed.
Reported midazolam onset ranged from five to fifteen minutes. Other onset and success estimates came from differing populations, protocols, and procedures. The review also distinguished procedural sedation from premedication before anesthesia.
Why a route does not define one exposure
Concentration, delivered volume, device, nasal conditions, and accompanying medicines can change uptake and experience. The review discussed stinging and unpleasant taste, which affect acceptance but are different outcomes from later sedation depth.
A limited single-database, English-language literature selection and diverse studies restrict comparative certainty. The paper’s broad safety conclusions should remain tied to the monitored settings and selected patients described.
Use in a clinical reconstruction
Document the actual formulation and delivery method rather than treating all intranasal midazolam as interchangeable. A literature onset range is not an exact prediction for a patient. This review cannot establish equal analgesia, equal respiratory risk, or superiority of one agent solely from cross-study percentages.
Source paper
Original analysis of the supplied journal article, identified as PMC5039613.